Research and Development

Many women suffer from morning sickness during the early stages of pregnancy and some suffer from hyperemesis gravidarum, acute morning …

The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …

Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …

A blast at Sun Pharma’s Ahmednagar factory caused the deaths of two workers and injured a further two. The four …

In March 2016, Amgen won two major patent cases against Sanofi and Regeneron over their drug, Praleunt, after it was …

The state of Texas has filed a lawsuit against the FDA to try to force a decision to be made …

The investigation into practices by Novartis in its Greek operations has been accelerated after the attempted suicide of a Greek …

With a new year comes a fresh start, and so it was the case with Sanofi and MSD’s joint vaccine …

Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …

Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …

Impax Laboratories announced on 20 December that CEO Frederik Wilkinson has left his position of president and CEO, as well …

What will be the key industry trends in 2017?Industry uncertaintyPerhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation …

Fluor Corporation has won an engineering, procurement and construction management contract for Novo Nordisk’s $2 billion diabetes active pharmaceutical ingredient …

The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …